Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02414269 |
| Title | Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Memorial Sloan Kettering Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) | Basking Ridge | New Jersey | United States | Details | ||
| Memorial Sloan Kettering Monmouth (Consent and Follow-Up) | Middletown | New Jersey | 07748 | United States | Details | |
| Memorial Sloan Kettering Bergen (Consent and Follow-Up) | Montvale | New Jersey | 07645 | United States | Details | |
| Memorial Sloan Kettering Commack (Consent and Follow-Up) | Commack | New York | United States | Details | ||
| Memorial Sloan Kettering Westchester (Consent and Follow-Up) | Harrison | New York | 10604 | United States | Details | |
| Memorial Sloan Kettering Cancer Center (Consent and Follow-Up) | New York | New York | 10065 | United States | Details |